You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Outcome in Phospholamban R14del Carriers
|
|---|---|
| Published in |
Circulation: Genomic and Precision Medicine, June 2014
|
| DOI | 10.1161/circgenetics.113.000374 |
| Pubmed ID | |
| Authors |
Ingrid A W van Rijsingen, Paul A van der Zwaag, Judith A Groeneweg, Eline A Nannenberg, Jan D H Jongbloed, Aeilko H Zwinderman, Yigal M Pinto, Ronald H Lekanne Dit Deprez, Jan G Post, Hanno L Tan, Rudolf A de Boer, Richard N W Hauer, Imke Christiaans, Maarten P van den Berg, J Peter van Tintelen, Arthur A M Wilde |
| Abstract |
-The pathogenic phospholamban (PLN) R14del mutation causes dilated and/or arrhythmogenic right ventricular cardiomyopathies and is associated with an increased risk of malignant ventricular arrhythmias and end-stage heart failure. We performed a multicentre study to evaluate mortality, cardiac disease outcome, and risk factors for malignant ventricular arrhythmias in a cohort of PLN R14del mutation carriers. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 17% |
| United States | 1 | 17% |
| Unknown | 4 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Scientists | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Unknown | 125 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 26 | 21% |
| Student > Bachelor | 15 | 12% |
| Researcher | 14 | 11% |
| Student > Master | 10 | 8% |
| Other | 7 | 6% |
| Other | 18 | 14% |
| Unknown | 36 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 47 | 37% |
| Biochemistry, Genetics and Molecular Biology | 16 | 13% |
| Agricultural and Biological Sciences | 9 | 7% |
| Computer Science | 2 | 2% |
| Immunology and Microbiology | 1 | <1% |
| Other | 9 | 7% |
| Unknown | 42 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2014.
All research outputs
#7,301,317
of 25,374,647 outputs
Outputs from Circulation: Genomic and Precision Medicine
#527
of 1,062 outputs
Outputs of similar age
#65,996
of 243,418 outputs
Outputs of similar age from Circulation: Genomic and Precision Medicine
#6
of 25 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1,062 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.0. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,418 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.